Gov. Gavin Newsom proposed spending $100 million to make insulin affordable to millions of people with diabetes under a new state generic drug label, CalRx. But state officials haven’t said how much the insulin will cost patients or how the state will deal with distribution and other challenges.
This article is sponsored by the Academy for Continued Healthcare Learning, an independently owned and operated full-service medical education company that has been developing certified healthcare education for nearly twenty years. It’s been over twent…
California has embarked on an ambitious five-year initiative to improve the health of its sickest Medicaid patients by introducing nontraditional services. In the Inland Empire, where many residents have diabetes, one health plan is diving into the experiment by delivering healthy, prepared meals to those lucky enough to get them.
California has embarked on an ambitious five-year initiative to improve the health of its sickest Medicaid patients by introducing nontraditional services. In the Inland Empire, where many residents have diabetes, one health plan is diving into the experiment by delivering healthy, prepared meals to those lucky enough to get them.
A diabetes diagnosis is not always related to a person’s weight or overall health, especially for those with Type 1 diabetes, who are dependent on insulin treatment for life.
Sens. Susan Collins (R-Maine) and Jeanne Shaheen (D-N.H.) are seeking to craft a compromise that members from both parties could accept. Their plan, still being ironed out, would not guarantee a specific limit on out-of-pocket costs but seeks to roll back insulin prices by barring rebate payments to pharmacy benefit managers.
Over their lifetimes, adults in the United States have a 40% chance of developing type 2 diabetes. And the likelihood for Latino adults is 25% higher. Even worse, Latinos develop type 2 diabetes when younger, and experience more severe complications an…
This analysis of insurance claims data finds that Congressional proposals to set a $35 per month cap on what people pay out of pocket for insulin would provide financial relief to at least 1 out of 5 insulin users with different types of private health…
Several legislative proposals in Congress propose a $35 per month cap on what people with health insurance would have to pay out of pocket for insulin, a life-saving hormone taken regularly by many people with diabetes to maintain their health. Such a …
Spun off from the ailing but not-quite-dead Build Back Better legislation, a popular proposal to cap out-of-pocket insulin costs at $35 a month faces tough political realities that could kill it.
